Vusion Ointment
NDC 0378-9730

View dosage, usage, ingredients, routes, and UNII mappings.

Product Information

Vusion (miconazole nitrate, zinc oxide, white petrolatum) is a NDA-approved product labeled by Mylan Pharmaceuticals Inc.. This product is used in children to treat diaper rash with a yeast infection, along with proper cleaning of the diaper area and frequent diaper changes. It is supplied as a ointment for topical administration. This product entry covers the primary NDC 0378-9730 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
0378-9730
Proprietary Name:
Vusion
Non-Proprietary Name: [1]
Miconazole Nitrate, Zinc Oxide, White Petrolatum
Substance Name: [2]
Miconazole Nitrate; Petrolatum; Zinc Oxide
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s): [4]
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Labeler & Regulatory Data

Labeler Code:
0378
FDA Application Number: [6]
NDA021026
Marketing Category: [8]
NDA - A product marketed under an approved New Drug Application.

Marketing Timeline

Start Marketing Date: [9]
02-06-2020
End Marketing Date: [10]
12-31-2026
Exclude Flag: [12]
N

Code Structure Chart

Product Details

What is NDC 0378-9730?

The NDC code 0378-9730 is assigned by the FDA to the product Vusion. It is commonly known by its generic name, miconazole nitrate, zinc oxide, white petrolatum. This pharmaceutical product is labeled by Mylan Pharmaceuticals Inc. and is currently categorized as listed product. The medication is a ointment administered via topical route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 0378-9730-50. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

This product is used in children to treat diaper rash with a yeast infection, along with proper cleaning of the diaper area and frequent diaper changes. Miconazole is an azole antifungal that works by preventing the growth of fungus. Zinc oxide and petrolatum work by forming a barrier on the skin to protect it from moisture and irritation. This product should not be used long-term or to prevent diaper rash. Unnecessary use or misuse of this product can lead to its decreased effectiveness.

What are Active Ingredients of this product?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
  • MICONAZOLE NITRATE 2.5 mg/g - An imidazole antifungal agent that is used topically and by intravenous infusion.
  • PETROLATUM 813.5 mg/g - A colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.
  • ZINC OXIDE 150 mg/g - A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 831391 - miconazole nitrate 0.25 % / zinc oxide 15 % / petrolatum 81.4 % Topical Ointment
  • RxCUI: 831391 - miconazole nitrate 0.0025 MG/MG / petrolatum 0.814 MG/MG / zinc oxide 0.15 MG/MG Topical Ointment
  • RxCUI: 831391 - Miconazole Nitrate 0.0025 MG/MG / Petrolatum 0.814 MG/MG / ZNO 0.15 MG/MG Topical Ointment
  • RxCUI: 831391 - miconazole nitrate 0.25 % / petrolatum, white 81.35 % / zinc oxide 15 % Topical Ointment
  • RxCUI: 831393 - Vusion 0.25 % / 15 % / 81.35 % Topical Ointment

Which are the Pharmacologic Classes of this product?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the End Marketing Date? This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".